Adjuvant therapy for gastric cancer – has the standard changed?

по Valle, J W
Опубликовано 2001

Why hasn't the National Institute been ‘NICE’ to patients with colorectal cancer?

по Saunders, M P, Valle, J W
Опубликовано 2002

Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer

по Saunders, M P, Valle, J W
Опубликовано 2003

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

по Lamarca, A., Foster, L., Satyadas, T., Siriwardena, A., Valle, J.W.
Опубликовано в: ESMO Open (2021)

Electroweak physics beyond the standard model /

по International Workshop on Electroweak Physics Beyond the standard model, Valle, J. W. F., Velasco, J.
Опубликовано 1992.

Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom

по Shabaruddin, F H, Elliott, R A, Valle, J W, Newman, W G, Payne, K
Опубликовано 2010

Reply: Guesstimates are not good enough for determining what is happening in routine care

по Shabaruddin, F H, Elliott, R A, Valle, J W, Newman, W G, Payne, K
Опубликовано 2010

Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study

по Sheikh, H Y, Valle, J W, Palmer, K, Sjursen, A, Craven, O, Wilson, G, Swindell, R, Saunders, M P
Опубликовано 2007

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study

по Valle, J W, Dangoor, A, Beech, J, Sherlock, D J, Lee, S M, Scarffe, J H, Swindell, R, Ranson, M
Опубликовано 2005

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer

по Saunders, M P, Hogg, M, Carrington, B, Sjursen, A-M, Allen, J, Beech, J, Swindell, R, Valle, J W
Опубликовано 2004

Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer

по Sheikh, H Y, Valle, J W, Waddell, T, Palmer, K, Wilson, G, Sjursen, A, Craven, O, Swindell, R, Saunders, M P
Опубликовано 2008

A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs

по Carrato, A., Falcone, A., Ducreux, M., Valle, J. W., Parnaby, A., Djazouli, K., Alnwick-Allu, K., Hutchings, A., Palaska, C., Parthenaki, I.
Опубликовано в: J Gastrointest Cancer (2015)

Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma

по Falk, S, Anthoney, A, Eatock, M, Van Cutsem, E, Chick, J, Glen, H, Valle, J W, Drolet, D W, Albert, D, Ferry, D, Ajani, J
Опубликовано 2006

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

по Khoja, L, Backen, A, Sloane, R, Menasce, L, Ryder, D, Krebs, M, Board, R, Clack, G, Hughes, A, Blackhall, F, Valle, J W, Dive, C
Опубликовано 2012

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality

по Dobson, R, Burgess, M I, Valle, J W, Pritchard, D M, Vora, J, Wong, C, Chadwick, C, Keevi, B, Adaway, J, Hofmann, U, Poston, G J, Cuthbertson, D J
Опубликовано в: Br J Cancer (2014)

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II stu...

по Valle, J W, Wasan, H, Johnson, P, Jones, E, Dixon, L, Swindell, R, Baka, S, Maraveyas, A, Corrie, P, Falk, S, Gollins, S, Lofts, F, Evans, L, Meyer, T, Anthoney, A, Iveson, T, Highley, M, Osborne, R, Bridgewater, J
Опубликовано 2009

Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder

по Kaupp-Roberts, S D, Yadegarfar, G, Friend, E, O'Donnell, C M, Valle, J W, Byrne, C, Bahar, I, Finch-Jones, M, Gillmore, R, Johnson, C D, Pereira, S P, Wiggers, J K, Pinto, M, Al-Sarireh, B, Ramage, J K
Опубликовано в: Br J Cancer (2016)

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrin...

по Kulke, M.H., Ruszniewski, P., Van Cutsem, E., Lombard-Bohas, C., Valle, J.W., De Herder, W.W., Pavel, M., Degtyarev, E., Brase, J.C., Bubuteishvili-Pacaud, L., Voi, M., Salazar, R., Borbath, I., Fazio, N., Smith, D., Capdevila, J., Riechelmann, R.P., Yao, J.C.
Опубликовано в: Ann Oncol (2017)

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given...

по Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G., Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, A., Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W.
Опубликовано в: Br J Cancer (2018)

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer

по Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G, Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, Alan, Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W.
Опубликовано в: Br J Cancer (2018)